Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
Sophie Melicine, Sophie Melicine, Paul Billoir, Paul Billoir, Dorothée Faille, Dorothée Faille, Erik Lerkevang Grove, Erik Lerkevang Grove, Minh Patrick Lê, Minh Patrick Lê, Nadine Ajzenberg, Nadine Ajzenberg, David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron (2023). Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases. , 7(5), DOI: https://doi.org/10.1016/j.rpth.2023.100201.
Article62 days agoDevelopment of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors
Nûn K. Bentounes, Nûn K. Bentounes, Sophie Melicine, Sophie Melicine, A. Martin, A. Martin, David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron (2023). Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors. , 48(2), DOI: https://doi.org/10.1016/j.jdmv.2023.04.002.
Article62 days agoNew anticoagulants in 2024: development of factor XI and XIa inhibitors
Nûn K. Bentounes, Nûn K. Bentounes, Sophie Melicine, Sophie Melicine, A. Martin, A. Martin, David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron (2024). New anticoagulants in 2024: development of factor XI and XIa inhibitors. , 36(5), DOI: https://doi.org/10.1684/stv.2024.1295.
Article62 days ago<scp>DOAC‐Remove</scp> to counteract the interference of <scp>anti‐Xa</scp> oral anticoagulants on the monitoring of heparin
Sophie Melicine, Sophie Melicine, Capucine Habay, Capucine Habay, Wiame Ghammad, Wiame Ghammad, Julie Carré, Julie Carré, Jean Luc Diehl, Jean Luc Diehl, David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron, Dominique Helley, Dominique Helley, Laëtitia Mauge, Laëtitia Mauge (2024). <scp>DOAC‐Remove</scp> to counteract the interference of <scp>anti‐Xa</scp> oral anticoagulants on the monitoring of heparin. , 46(5), DOI: https://doi.org/10.1111/ijlh.14321.
Article62 days agoDabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases
Sophie Melicine, Sophie Melicine, Paul Billoir, Paul Billoir, Dorothée Faille, Dorothée Faille, Erik Lerkevang Grove, Erik Lerkevang Grove, Minh Patrick Lê, Minh Patrick Lê, Nadine Ajzenberg, Nadine Ajzenberg, David M. Smadja, David M. Smadja, Nicolas Gendron, Nicolas Gendron (2023). Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases. , 7(5), DOI: https://doi.org/10.1016/j.rpth.2023.100201.
Article62 days ago